Compare RVYL & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVYL | SSKN |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 8.9M |
| IPO Year | N/A | 2005 |
| Metric | RVYL | SSKN |
|---|---|---|
| Price | $6.31 | $1.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 838.4K | 57.1K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,858,000.00 | $30,980,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $297.49 | $7.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 29.50 | N/A |
| 52 Week Low | $4.50 | $1.18 |
| 52 Week High | $81.55 | $3.86 |
| Indicator | RVYL | SSKN |
|---|---|---|
| Relative Strength Index (RSI) | 65.03 | 40.66 |
| Support Level | $5.30 | $1.18 |
| Resistance Level | $7.68 | $1.35 |
| Average True Range (ATR) | 1.03 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 39.58 | 35.20 |
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.